Kamil Ali-Jackson

Kamil Ali-Jackson

Direttore/Membro del Consiglio presso RIGEL PHARMACEUTICALS, INC.

Patrimonio netto: 86 476 $ in data 30/04/2024

65 anni
Health Technology
Consumer Services
Retail Trade

Profilo

Kamil Ali-Jackson is the founder of NeXeption LLC (founded in 2011), Aclaris Therapeutics, Inc. (founded in 2012), and Nexeption, Inc. (founded in 2011).
Ms. Ali-Jackson's current jobs include being an Independent Director at Rigel Pharmaceuticals, Inc., Moda Operandi, Inc., and PDS Biotechnology Corp.
Ms. Ali-Jackson is also a Trustee at Rosemont College and Princeton University.
Ms. Ali-Jackson's former jobs include being a Director at PDS Operating Corp., Legal Counsel at Merck & Co., Inc. (from 1990 to 1998), Secretary, Chief Compliance & Legal Officer at Ceptaris Therapeutics, Inc. (from 2011 to 2013), Secretary & General Counsel at Ception Therapeutics, Inc. (from 2006 to 2010), Vice President & Associate General Counsel at Endo Pharmaceuticals, Inc. (from 1998 to 2000), General Counsel at Caresoft, Inc., Vice President-Legal & Associate General Counsel at Dr. Reddy's Laboratories, Inc. (from 2004 to 2006), Interim General Counsel at Iroko Pharmaceuticals LLC (from 2011 to 2012), and Chief Legal Officer at Network Sensing Technologies LLC.
Ms. Ali-Jackson was also a Chief Legal Officer at Ralexar Therapeutics, Inc. (from 2014 to 2015).
Ms. Ali-Jackson's education includes an undergraduate degree from Princeton University and a graduate degree from Harvard Law School (conferred in 1984).

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
31/01/2024 43 750 ( 0.02% ) 48 125 $ 30/04/2024
14/07/2023 11 764 ( 0.03% ) 38 351 $ 30/04/2024

Posizioni attive di Kamil Ali-Jackson

SocietàPosizioneInizio
PDS BIOTECHNOLOGY CORPORATION Direttore/Membro del Consiglio 21/02/2020
RIGEL PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 16/12/2021
Direttore/Membro del Consiglio -
Rosemont College Direttore/Membro del Consiglio -
Nst Consulting LLC Consigliere Generale 01/05/2011
Nexeption II LLC Consigliere Generale 01/01/2011
Princeton University Direttore/Membro del Consiglio -
Tutte le posizioni attive di Kamil Ali-Jackson

Precedenti posizioni note di Kamil Ali-Jackson

SocietàPosizioneFine
ACLARIS THERAPEUTICS, INC. Fondatore 03/01/2022
Fondatore 31/12/2020
░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Kamil Ali-Jackson

Formazione di Kamil Ali-Jackson

Princeton University Undergraduate Degree
Harvard Law School Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kamil Ali-Jackson

Relazioni

100 +

Relazioni di 1° grado

21

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa4
MERCK & CO., INC.

Health Technology

RIGEL PHARMACEUTICALS, INC.

Health Technology

ACLARIS THERAPEUTICS, INC.

Health Technology

PDS BIOTECHNOLOGY CORPORATION

Health Technology

Aziende private14

Health Technology

Health Technology

Health Technology

Retail Trade

Health Technology

Technology Services

Health Services

Health Technology

Industrial Services

Health Technology

Health Technology

Nexeption, Inc.

Nexeption II LLC

Nst Consulting LLC

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Kamil Ali-Jackson